OracleScan monitored market evidence

xyz:NVDA

critical condition with complete evidence coverage.

• Oracle 222.09; mark 222.1
• Observed open interest $141,843,130
• Observed at 2026-09-20T01:07:59.024Z
• All configured health components available

Open interactive retained evidence